Dermapharm Holding SE buy DirectorDealer
Summary
This prediction ended on 14.10.23 with a price of €39.02. During the runtime of the prediction for Dermapharm Holding SE the price only changed by -0.71%. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -0.842% | -0.842% | -17.561% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Themis Beteiligungs-Aktiengesellschaft (in enger Beziehung)
- Handelstag: 12.10.2022
- Volumen: 55825000 €
- Meldende_r: Themis Beteiligungs-Aktiengesellschaft
In the thread Trading Dermapharm Holding SE